On-demand use of tramadol, sildenafil, paroxetine and local anaesthetics for the management of premature ejaculation: A randomised placebo-controlled clinical trial
- PMID: 26558110
- PMCID: PMC4443019
- DOI: 10.1016/j.aju.2013.05.003
On-demand use of tramadol, sildenafil, paroxetine and local anaesthetics for the management of premature ejaculation: A randomised placebo-controlled clinical trial
Abstract
Objectives: To compare the clinical efficacy of the on-demand use of four drugs in the management of patients with premature ejaculation (PE), as the off-label use of selective serotonin-reuptake inhibitors and topical penile anaesthetics is frequently indicated for the management of patients with PE, and tramadol HCl and sildenafil citrate were also tried for managing this disorder, but with recommendations based on weak evidence.
Patients and methods: This was a single-centre, single-blind, placebo-controlled clinical trial conducted on 150 patients who had PE for >1 year. Patients were randomised equally into five groups. On-demand tramadol, sildenafil, paroxetine, local lidocaine gel or placebo was given for patients in groups 1-5, respectively. During the month before treatment, the intravaginal ejaculation latency time (IELT) and sexual satisfaction scores (on a 0-5-point scale) were measured and compared to the mean IELT and sexual satisfaction scores recorded during 4 weeks of on-demand drug administration, with monitoring of any possible side-effects.
Results: Tramadol-treated patients had a significantly longer mean (SD) IELT, of 351 (119) s, than the other groups. Local anaesthetic was significantly better than paroxetine in prolonging the IELT, at 278 (111) vs. 186 (65) s, respectively. The improvement in sexual satisfaction was significantly better in the sildenafil group, with a mean (SD) improvement of 2.9 (1) points, than in the paroxetine and local anaesthetic groups, at 2.2 (0.9) and 1.9 (0.9) points, respectively.
Conclusions: The four drugs significantly improved IELT values over placebo. Tramadol was associated with significantly longer IELT values, whilst sildenafil induced significantly better sexual satisfaction than the other drugs. The four drugs had tolerable side-effects.
Keywords: ED, erectile dysfunction; IELT, intravaginal ejaculation latency time; IIEF-5, International Index of Erectile Function-5.; Local anaesthetics; PDE-5i, phosphodiesterase-5 inhibitor; PE, premature ejaculation; Paroxetine; Premature ejaculation; SSRI, selective serotonin-reuptake inhibitor; Sildenafil; Tramadol.
Similar articles
-
Comparison of the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation: A randomised placebo-controlled clinical trial.Andrologia. 2018 Feb;50(1). doi: 10.1111/and.12829. Epub 2017 May 12. Andrologia. 2018. PMID: 28497478 Clinical Trial.
-
Evaluation of tramadol on demand vs. daily paroxetine as a long-term treatment of lifelong premature ejaculation.J Sex Med. 2010 Aug;7(8):2860-7. doi: 10.1111/j.1743-6109.2010.01789.x. Epub 2010 Mar 30. J Sex Med. 2010. PMID: 20367773 Clinical Trial.
-
A systematic review and meta-analysis of randomized controlled trials of "on-demand" use of tramadol vs "on-demand" use of paroxetine in the management of patients with premature ejaculation.Int J Clin Pract. 2021 Nov;75(11):e14825. doi: 10.1111/ijcp.14825. Epub 2021 Sep 16. Int J Clin Pract. 2021. PMID: 34492139
-
Tramadol HCL has promise in on-demand use to treat premature ejaculation.J Sex Med. 2008 Jan;5(1):188-93. doi: 10.1111/j.1743-6109.2006.00424.x. Epub 2007 Mar 14. J Sex Med. 2008. PMID: 17362279 Clinical Trial.
-
The role of phosphodiesterase type 5 inhibitors in the management of premature ejaculation: a critical analysis of basic science and clinical data.Eur Urol. 2007 Nov;52(5):1331-9. doi: 10.1016/j.eururo.2007.08.005. Epub 2007 Aug 17. Eur Urol. 2007. PMID: 17728050 Review.
Cited by
-
Tramadol for premature ejaculation: a systematic review and meta-analysis.BMC Urol. 2015 Jan 30;15:6. doi: 10.1186/1471-2490-15-6. BMC Urol. 2015. PMID: 25636495 Free PMC article.
-
Phosphodiesterase-5 Inhibitors for Premature Ejaculation: Systematic Review and Meta-Analysis of Placebo-Controlled Trials.Am J Mens Health. 2020 May-Jun;14(3):1557988320916406. doi: 10.1177/1557988320916406. Am J Mens Health. 2020. PMID: 32375542 Free PMC article.
-
Premature ejaculation: challenging new and the old concepts.F1000Res. 2017 Dec 4;6:2084. doi: 10.12688/f1000research.12150.1. eCollection 2017. F1000Res. 2017. PMID: 29259775 Free PMC article. Review.
-
Paroxetine in the treatment of premature ejaculation: a systematic review and meta-analysis.BMC Urol. 2019 Jan 3;19(1):2. doi: 10.1186/s12894-018-0431-7. BMC Urol. 2019. PMID: 30606186 Free PMC article.
-
Clinical review of ejaculatory dysfunction.Reprod Med Biol. 2019 Jul 24;18(4):331-343. doi: 10.1002/rmb2.12289. eCollection 2019 Oct. Reprod Med Biol. 2019. PMID: 31607793 Free PMC article. Review.
References
-
- Porst H., Montorsi F., Rosen R.C., Gaynor L., Grupe S., Alexander J. The premature ejaculation prevalence and attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol. 2007;51:816–823. - PubMed
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Text Revision. (DSM-IV-TR). Washington, DC. American Psychiatric Association, 2000: 554.
-
- Hatzimouratidis K., Amar E., Eardley I., Giuliano F., Hatzichristou D., Montorsi F. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol. 2010;57:804–814. - PubMed
-
- Althof S.E., Symonds T. Patient reported outcomes used in the assessment of premature ejaculation. Urol Clin North Am. 2007;34:581–589. - PubMed
-
- Porst H., Vardi Y., Akkus E., Melman A., Park N.C., Seftel A.D. Standards for clinical trials in male sexual dysfunctions. J Sex Med. 2010;7:414–444. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources